文献速递产科母胎医学

硫酸镁治疗子痫前期与子痫的临床实践模式:一项多国调查

Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey.
PubMed 文献 · BJOG · 2016-11-24

该横断面调查于2015年覆盖非洲、拉丁美洲和亚洲15个国家147家医疗机构,评估硫酸镁用于子痫预防和治疗的实践模式。结果显示87.4%机构始终备有硫酸镁、86.4%备有正式给药方案,但用于轻度子痫前期仅24.3%机构,且给药方案与国际推荐 largely 不一致。

要点

  • 147家机构中87.4%始终备有硫酸镁,86.4%备有正式给药方案。
  • 硫酸镁用于轻度子痫前期、重度子痫前期和子痫的机构比例分别为24.3%、93.5%和96.4%。
  • 重度子痫前期治疗中,26.4%和7.0%机构分别使用与Zuspan和Pritchard方案一致的给药方案。

核心结论

  • 报告的硫酸镁用于子痫预防和治疗的临床实践差异很大,且在很大程度上与当前国际建议不一致。

研究设计与样本

  • 横断面调查,2015年以匿名在线和纸质问卷进行,覆盖非洲、拉丁美洲和亚洲15个国家的147家医疗机构,对象为产科主任或产房负责人。

主要发现

  • 87.4%的机构报告硫酸镁始终可用,86.4%报告正式给药方案始终可用。
  • 硫酸镁用于轻度子痫前期、重度子痫前期和子痫治疗的机构比例分别为24.3%、93.5%和96.4%。
  • 重度子痫前期治疗中,26.4%的机构使用与Zuspan方案一致的给药方案,7.0%使用与Pritchard方案一致的给药方案。
  • 非洲地区肌肉注射维持方案使用率(45.7%)高于拉丁美洲(3.0%)和亚洲(22.9%);拉丁美洲(94.0%)和亚洲(60.0%)静脉维持方案使用率高于非洲(21.7%)。
  • 子痫治疗在不同区域间呈现相似模式。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterise the current clinical practice patterns regarding the use of magnesium sulphate (MgSO4 ) for eclampsia prevention and treatment in a multi-country network of health facilities and compare with international recommendations. DESIGN: Cross-sectional survey. SETTING: A total of 147 health facilities in 15 countries across Africa, Latin America and Asia. POPULATION: Heads of obstetric departments or maternity units. METHODS: Anonymous online and paper-based survey conducted in 2015. MAIN OUTCOME MEASURES: Availability and use of MgSO4 ; availability of a formal clinical protocol for MgSO4 administration; and MgSO4 dosing regimens for eclampsia prevention and treatment. RESULTS: Magnesium sulphate and a formal protocol for its administration were reported to be always available in 87.4% and 86.4% of all facilities, respectively. MgSO4 was used for the treatment of mild pre-eclampsia, severe pre-eclampsia and eclampsia in 24.3%, 93.5% and 96.4% of all facilities, respectively. Regarding the treatment of severe pre-eclampsia, 26.4% and 7.0% of all facilities reported using dosing regimens that were consistent with Zuspan and Pritchard regimens, respectively. Across regions, intramuscular maintenance regimens were more commonly used in the African region (45.7%) than in the Latin American (3.0%) and Asian (22.9%) regions, whereas intravenous maintenance regimens were more often used in the Latin American (94.0%) and Asian (60.0%) regions than in the African region (21.7%). Similar patterns were found for the treatment of eclampsia across regions. CONCLUSIONS: The reported clinical use of MgSO4 for eclampsia prevention and treatment varied widely, and was largely inconsistent with current international recommendations. TWEETABLE ABSTRACT: MgSO4 regimens for eclampsia prevention and treatment in many hospitals are inconsistent with international recommendations.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Long Q, Oladapo OT, Leathersich S, et al. Clinical practice patterns on the use of magnesium sulphate for treatment of pre-eclampsia and eclampsia: a multi-country survey. BJOG. 2016. PMID: 27885772. doi:10.1111/1471-0528.14400

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。